Mumbai: Global pharma major Lupin Limited has announced the launch of an authorized generic version of Ravicti (Glycerol ...

Key Highlights Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up ...

Pittsburgh: Viatris Inc., a global healthcare company, has announced it has acquired Aculys Pharma, Inc., a clinical-stage ...

A large study shows risperidone raises stroke risk in patients with dementia, even those without cardiovascular disease — ...

Choosing the right career path after completing 12th grade in the science stream is crucial for securing a lucrative and ...

The NIAGARA trial showed that adding durvalumab to neoadjuvant chemotherapy in MIBC patients did not negatively impact HRQOL outcomes. Significant improvement in event-free survival was observed with ...

Median disease-free survival (DFS) increased from 4.8 months with placebo to 9.9 months with adjuvant atezolizumab (Tecentriq ...

Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients[i] New findings from this investigational study build on the strength of the data for amivantamab in ...

For years, life-changing treatments for rheumatic diseases remained out of reach for most Bangladeshis. Today, local innovation and medical leadership are rewriting that story — bringing hope, dignity ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

Figuring out how to lose weight and keep it off is a big challenge but a new study from the Cleveland Clinic details some ...

When machine learning is used to suggest new potential scientific insights or directions, algorithms sometimes offer ...